炎症性肠病的治疗药物监测：患者指南 - Suppr | 超能文献

Therapeutic Drug Monitoring in Inflammatory Bowel Disease: A Patient Guide.

出版信息

Gastroenterology. 2017 Sep;153(3):860-861. doi: 10.1053/j.gastro.2017.07.037. Epub 2017 Jul 31.

DOI:10.1053/j.gastro.2017.07.037

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Therapeutic Drug Monitoring in Inflammatory Bowel Disease: A Patient Guide.炎症性肠病的治疗药物监测：患者指南

Gastroenterology. 2017 Sep;153(3):860-861. doi: 10.1053/j.gastro.2017.07.037. Epub 2017 Jul 31.

2

American Gastroenterological Association Institute Guideline on Therapeutic Drug Monitoring in Inflammatory Bowel Disease.美国胃肠病学会关于炎症性肠病治疗药物监测的学会指南。

Gastroenterology. 2017 Sep;153(3):827-834. doi: 10.1053/j.gastro.2017.07.032. Epub 2017 Aug 3.

3

Therapeutic Drug Monitoring in Inflammatory Bowel Disease: Clinical Decision Support Tool.炎症性肠病的治疗药物监测：临床决策支持工具

Gastroenterology. 2017 Sep;153(3):858-859. doi: 10.1053/j.gastro.2017.07.039. Epub 2017 Aug 1.

4

Using Proactive Therapeutic Drug Monitoring of Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease: From an Old Concept to a Future Standard of Care?在炎症性肠病中对抗肿瘤坏死因子治疗进行前瞻性治疗药物监测：从一个旧概念到未来的护理标准？

Gastroenterology. 2018 Mar;154(4):1201-1202. doi: 10.1053/j.gastro.2018.01.001. Epub 2018 Feb 10.

5

Usefulness of mean corpuscular volume as a surrogate marker for monitoring thiopurine treatment in inflammatory bowel disease.平均红细胞体积作为监测炎症性肠病硫嘌呤治疗替代指标的实用性。

Eur J Gastroenterol Hepatol. 2016 Sep;28(9):991-6. doi: 10.1097/MEG.0000000000000675.

6

Update on pathogenesis and predictors of response of therapeutic strategies used in inflammatory bowel disease.炎症性肠病治疗策略的发病机制及反应预测因素的最新进展

World J Gastroenterol. 2015 Nov 28;21(44):12519-43. doi: 10.3748/wjg.v21.i44.12519.

7

Managing Crohn's Disease After Surgery: A Patient Guide.手术后克罗恩病的管理：患者指南

Gastroenterology. 2017 Jan;152(1):296-297. doi: 10.1053/j.gastro.2016.11.039. Epub 2016 Nov 26.

8

Dosing 6-thioguanine in inflammatory bowel disease: expert-based guidelines for daily practice.炎症性肠病中巯嘌呤的剂量：日常实践的专家指南。

J Gastrointestin Liver Dis. 2010 Sep;19(3):291-4.

9

Guidelines for the management of inflammatory bowel disease in adults.成人炎症性肠病管理指南。

Gut. 2004 Sep;53 Suppl 5(Suppl 5):V1-16. doi: 10.1136/gut.2004.043372.

10

On therapeutic drug monitoring of thiopurines in inflammatory bowel disease; pharmacology, pharmacogenomics, drug intolerance and clinical relevance.炎症性肠病中硫嘌呤类药物的治疗药物监测：药理学、药物基因组学、药物不耐受及临床相关性。

Curr Drug Metab. 2009 Nov;10(9):981-97. doi: 10.2174/138920009790711887.

引用本文的文献

1

Electroacupuncture and Moxibustion Improved Anxiety Behavior in DSS-Induced Colitis Mice.电针和艾灸改善了葡聚糖硫酸钠诱导的结肠炎小鼠的焦虑行为。

Gastroenterol Res Pract. 2019 Feb 7;2019:2345890. doi: 10.1155/2019/2345890. eCollection 2019.

2

Therapeutic drug monitoring in inflammatory bowel disease: too little too early?-comments on the American Gastroenterology Association Guideline.炎症性肠病中的治疗药物监测：为时过早且力度不足？——对美国胃肠病学会指南的评论

Transl Gastroenterol Hepatol. 2017 Dec 19;2:113. doi: 10.21037/tgh.2017.12.05. eCollection 2017.